GANX Gain Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology

Get AI intraday signals

GANX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For GANX
(Try 14 days for Free)

View a ticker or compare two or three

Compare

GANX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For GANX
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

GANX is expected to report earnings to rise 20.35% to -20 cents per share on March 20

Gain Therapeutics GANX Stock Earnings Reports

Q4'24

Est.

$-0.20

Q3'24

Beat

by $0.04

Q2'24

Missed

by $0.23

Q1'24

Beat

by $0.09

Q4'23

Beat

by $0.04

The last earnings report on November 14 showed earnings per share of -17 cents, beating the estimate of -20 cents. With 156.02K shares outstanding, the current market capitalization sits at 44.56M.

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

4800 Montgomery Lane

Phone

+1 301 500-1556

Employees

Web

https://www.gaintherapeutics.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
GME	27.37	0.91	+3.44%
GameStop Corp
AAPL	228.22	3.10	+1.38%
Apple
SPY	593.35	-3.84	-0.64%
SPDR® S&P 500® ETF Trust
BTC.X	87250.430000	-3333.734400	-3.68%
Bitcoin cryptocurrency
TSLA	311.18	-19.06	-5.77%
Tesla

GANX and Stocks

Correlation & Price change

A.I.dvisor tells us that GANX and CRMD have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GANX and CRMD's prices will move in lockstep.

Ticker / NAME	Correlation To GANX	1D Price Change %
GANX	100%	-14.04%
CRMD - GANX	30% Poorly correlated	-3.08%
OCUL - GANX	26% Poorly correlated	-6.42%
COYA - GANX	26% Poorly correlated	-5.94%
CARA - GANX	26% Poorly correlated	+1.08%
HOWL - GANX	25% Poorly correlated	-5.85%
More